ACROBiosystems and SeromYx Systems Announce Strategic Collaboration on Comprehensive Functional Profiling of Anti-CD20 Monoclonal Antibodies

by | PRNewswire Asia

TOKYO and NEWARK, Del., April 30, 2026 /PRNewswire/ — ACROBiosystems, a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries, has entered into a research collaboration with SeromYx Systems, specializing in advanced...

Ascletis to Present Data on Multiple Programs at the American Diabetes Association's 2026 Scientific Sessions

by | PRNewswire Asia

HONG KONG, April 30, 2026 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today poster presentations highlighting multiple programs at the American Diabetes Association’s (ADA’s) 2026 Scientific Sessions, taking place...

ACROBiosystems collaborates with Carterra, accelerating large-scale characterization of potential drug candidates

by | PRNewswire Asia

TOKYO and NEWARK, Del., April 30, 2026 /PRNewswire/ — ACROBiosystems, a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries, announces its collaboration with Carterra, a company focused on innovative technologies...

himchanmaru to Join Korea Trade Shows, Accelerates Global Market Expansion.

by | PRNewswire Asia

SEOUL, South Korea, April 30, 2026 /PRNewswire/ — himchanmaru is set to expand its global footprint by participating in major food exhibitions in Korea later this year. The company will take part in Food Week Korea 2026, scheduled to be held at COEX in November,...

Epsium Enterprise Limited Files Annual Report on Form 20-F for Fiscal Year 2025

by | PRNewswire Asia

MACAU, April 30, 2026 /PRNewswire/ — Epsium Enterprise Limited (Nasdaq: EPSM) (the "Company" or "Epsium"), an importer and wholesaler of premium alcoholic beverages in Macau, today announced that it has filed its Annual Report on Form 20-F...

EirGenix Advances into CPHI Japan, Capitalizing on Market Trends to Deepen Its Strategic Footprint in Japan

by | PRNewswire Asia

TOKYO, April 29, 2026 /PRNewswire/ — As the global biopharmaceutical industry undergoes rapid restructuring, two powerful forces—policy evolution and supply chain transformation—are reshaping Japan’s landscape. On one side, the Ministry of Health,...